Shared more. Cited more. Safe forever.
    • advanced search
    • submit works
    • about
    • help
    • contact us
    • login
    View Item 
    •   MOspace Home
    • University of Missouri-Kansas City
    • School of Graduate Studies (UMKC)
    • Theses and Dissertations (UMKC)
    • Dissertations (UMKC)
    • 2013 Dissertations (UMKC)
    • 2013 UMKC Dissertations - Freely Available Online
    • View Item
    •   MOspace Home
    • University of Missouri-Kansas City
    • School of Graduate Studies (UMKC)
    • Theses and Dissertations (UMKC)
    • Dissertations (UMKC)
    • 2013 Dissertations (UMKC)
    • 2013 UMKC Dissertations - Freely Available Online
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    advanced searchsubmit worksabouthelpcontact us

    Browse

    All of MOspaceCommunities & CollectionsDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis SemesterThis CollectionDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis Semester

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular AuthorsStatistics by Referrer

    EVASION OF EFFLUX AND ENHANCING BIOAVAILABILITY OF AMPRENAVIR BY PRODRUG DERIVATIZATION

    Mandava, Nanda K.
    View/Open
    [PDF] EVASION OF EFFLUX AND ENHANCING BIOAVAILABILITY OF AMPRENAVIR BY PRODRUG DERIVATIZATION (3.134Mb)
    Date
    2013
    Format
    Thesis
    Metadata
    [+] Show full item record
    Abstract
    Millions of people worldwide have been infected with human immunodeficiency (HIV). Highly active antiretroviral therapy (HAART) has substantially improved the clinical management of HIV-1 infection. Inclusion of HIV protease inhibitors (PIs) in HAART has substantially improved clinical outcomes of HIV infected patients. However complete eradication of virus poses an unmet goal. Major challenge with current anti-HIV drug regimen is the inability of PIs to attain sufficient concentrations in sanctuary sites such as brain resulting in persistent viral replication and may lead to viral resistance. Sub-therapeutic concentration of PIs in brain leads to drug resistance and HIV associated dementia. One of the major factors which limit central nervous system (CNS) permeation of PIs is the presence of efflux proteins on brain capillary endothelial cells. There are several reports demonstrating that PIs are substrates of efflux proteins which limit their oral bioavailability and brain permeation. Various approaches have been employed to evade the efflux and improve the bioavailability, however improving brain absorption still remains as an elusive goal. The overall objective of this dissertation project was to improve oral and brain bioavailability of Amprenavir (APV) by prodrug strategies targeting nutrient transporters to bypass P-glycoprotein (P-gp) mediated efflux. APV has low bioavailability and negligible brain absorption which is attributed by low aqueous solubility, efflux mediated by multidrug resistance proteins, extensive metabolism and protein binding. In order to improve oral bioavailability and absorption across blood brain interfaces, di-peptide and amino acid prodrugs of APV (Val-Val-APV, Gly-Val-APV, Val-APV) were synthesized and evaluated for interaction with efflux and influx transporters, enzymatic hydrolysis, and bioavailability. These prodrugs targeting peptide transporters were demonstrated to evade P-gp mediated efflux and exhibit better permeability characteristics compared to APV. All these prodrugs have higher aqueous solubility. Enzymatic stability and metabolism studies demonstrated that these prodrugs undergo enzymatic hydrolysis and regenerate parent drug which exerts pharmacological action. Oral and brain absorption of prodrugs was much higher as compared to APV in Sprague-Dawley rats. Thus transporter targeted prodrug modification of P-gp substrates could lead to shielding of these drug molecules from efflux pumps and improve bioavailability of PIs and other P-gp substrates
    Table of Contents
    ABSTRACT -- ILLUSTRATIONS -- TABLES -- ACKNOWLEDGEMENTS -- INTRODUCTION -- LITERATURE REVIEW -- CIRCUMVENTION OF P-GP MEDIATED EFFLUX AND ENHANCING PERMEABILITY OF AMPRENAVIR BY PRODRUG DERIVATIZATION -- PROTEIN BINDING, METABOLIC AND ENZYMATIC STABILITY OF AMPRENAVIR PRODRUGS -- ORAL PHARMACOKINETICS OF AMPRENAVIR AND PRODRUGS -- ABSORPTION OF AMPRENAVIR PRODRUGS ACROSS BLOOD BRAIN INTERFACES -- SUMMARY AND RECOMMENDATIONS -- APPENDIX -- REFERENCES
    URI
    http://hdl.handle.net/10355/43463
    Degree
    Ph. D.
    Thesis Department
    Pharmacy (UMKC)
     
    Chemistry (UMKC)
     
    Collections
    • 2013 UMKC Dissertations - Freely Available Online
    • Chemistry Electronic Theses and Dissertations (UMKC)
    • Pharmaceutical Sciences Electronic Theses and Dissertations (UMKC)

    If you encounter harmful or offensive content or language on this site please email us at harmfulcontent@umkc.edu. To learn more read our Harmful Content in Library and Archives Collections Policy.

    Send Feedback
    hosted by University of Missouri Library Systems
     

     


    If you encounter harmful or offensive content or language on this site please email us at harmfulcontent@umkc.edu. To learn more read our Harmful Content in Library and Archives Collections Policy.

    Send Feedback
    hosted by University of Missouri Library Systems